Press archive
- Increased equity capital to support transformation process
(12 December 2017) - Increased equity capital to support transformation process
(12 December 2017) - Revenue increase in the first nine months of 2017, operating earnings situation remains weak
(15 November 2017) - Semperit and Shaw Almex agree to end their cooperation agreement for the North American conveyor belt market
(13 November 2017) - Sempermed at Medica 2017: Experience Sustainability
(12 November 2017) - Semperit Group on a rapid growth path with hydraulic hoses
() - New major contracts for Sempertrans and new management team
(19 October 2017) - Protection for the skin and the planet - Semperguard® green at the A+A 2017 in Düsseldorf
(17 October 2017) - Semperit: Agreement on social plan for French Production site in Argenteuil signed
(13 October 2017) - Earnings development significantly weaker than expected
(09 October 2017) - Final decision from Court against former exclusivity clause, no impact on ongoing Sempermed business
(04 October 2017) - Continued revenue growth in half-year 2017, first measures in transition phase taken
(17 August 2017) - Impairment of approx. EUR 26 million in Sempermed segment
(27 July 2017) - Semperit decided to effect cost-saving/restructuring measures for its Sempertrans production site in Argenteuil, France
(30 June 2017) - Semperit Profiles expands production site in Deggendorf
(26 June 2017) - Martin Füllenbach has started as new Chairman of the Management Board
(01 June 2017) - Annual General Meeting resolves to distribute a dividend of EUR 0.70 per share
(23 May 2017) - High earnings growth due to one-off effects in Q1 2017
(16 May 2017) - Richard Ehrenfeldner steps down from the Management Board of Semperit AG Holding
(14 April 2017) - Very weak operating Q1 2017 result expected / Semperit suspends outlook
(10 April 2017) - Very weak operating Q1 2017 result expected / Semperit suspends outlook
(10 April 2017) - Martin Füllenbach to be new CEO of Semperit AG Holding
(27 March 2017) - Semperit and Sri Trang finalise termination of almost all joint venture activities // Thomas Fahnemann to leave Semperit
(15 March 2017) - Resignation of CEO Thomas Fahnemann
(15 March 2017) - Semperit impacted by weak market environment and one-off effects in 2016
(10 March 2017) - Semperit and Sri Trang sign an agreement on the demerger of the joint venture Siam Sempermed // Significant one-time accounting effects in 2016/2017
(18 January 2017) - Semperit and Sri Trang sign an agreement on the demerger of the joint venture Siam Sempermed
(18 January 2017)